1-tetradecanol complex

1-tetradecanol complex (1-TDC) is a proprietary anti-inflammatory small molecule complex developed by Imagenetix for the treatment and prevention of periodontal disease. Formulated as a topical compound for application directly to the gum line, 1-TDC is designed to halt the progression of gum and bone damage. Research conducted at Boston University and published in *The Journal of Periodontology* has demonstrated that the compound can significantly improve tissue and bone health by preventing inflammatory cell infiltration. While the 1-TDC complex is widely available as a joint and oral health supplement in the veterinary market for companion animals, Imagenetix has positioned the compound as a human therapeutic candidate, advancing it toward Phase 1 clinical trials under the FDA regulatory pathway.

Other names

1-tetradecanol complex1-TDC